Concepedia

Yvonne Kienast

YK

Statistics

Publications

19

Citations

3.5K

H-Index

15

Active since

2006

Affiliations

Roche Pharma AG (Germany)(Current)

Roche (Switzerland)

Ludwig-Maximilians-Universität München

University Hospital Heidelberg

Heidelberg University

Yvonne Kienast is an author at Roche Pharma AG (Germany) specializing in oncology, angiogenesis, and medicine.

ORCID

Publications per year

2006–2022

19

Publications

19

Real-time imaging reveals the single steps of brain metastasis formation

Yvonne Kienast, Louisa von Baumgarten, Martin Fuhrmann et al. · Nature Medicine · 2009 · 1.1K citations

, , +15

Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade

Martina Schmittnaegel, Nicolò Rigamonti, Ece Kadioglu et al. · Science Translational Medicine · 2017 · 579 citations · Full text

, , +17

Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling

Moritz Felcht, Robert Luck, Alexander Schering et al. · Journal of Clinical Investigation · 2012 · 476 citations · Full text

, , +13

Imaging glioma cell invasion <i>in vivo</i> reveals mechanisms of dissemination and peritumoral angiogenesis

Frank Winkler, Yvonne Kienast, Martin Fuhrmann et al. · Glia · 2009 · 219 citations

, , +15

Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity

Sabine Hoves, Chia-Huey Ooi, Hadassah Sade et al. · The Journal of Experimental Medicine · 2018 · 215 citations · Full text

, , +17

1–5 of 19